Entecavir: stability and drug-excipient compatibility
Abstract Entecavir is an inhibitor of hepatitis B virus (HBV) DNA synthesis that has been widely prescribed in the treatment of chronic infections caused by the virus. Production of generic ETV drugs is an ongoing global endeavor, with particular significance for developing countries that rely on im...
Saved in:
Main Authors: | Ariadne Botto Fiorot, Clayton Raynan dos Santos, Thiago Padovani Xavier, Taisa Shimosakai de Lira, Marcelo Antonio de Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2025-01-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100304&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of entecavir in renal graft recipients with chronic hepatitis B
by: M. L. Zubkin, et al.
Published: (2011-09-01) -
Development of a new HPLC method for wogonin in rat plasma: Compatibility of standard and test samples
by: Salmani Jumah Masoud Mohammad, et al.
Published: (2017-09-01) -
Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
by: Lu Cao, et al.
Published: (2025-01-01) -
Application of instrumented nanoindentation in preformulation studies of pharmaceutical active ingredients and excipients
by: Egart Mateja, et al.
Published: (2016-09-01) -
Compatible mappings and common fixed points revisited
by: Gerald Jungck
Published: (1994-01-01)